WCM Investment Management
GSK icon

WCM Investment Management’s GSK GSK Stock Holding History

WCM Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,824
Closed -$251K – 112
2015
Q2 		$251K Hold
4,824
– – 0.01% 112
2015
Q1 		$278K Sell
4,824
-372
-7% -$21.3K 0.01% 138
2014
Q4 		$278K Sell
5,196
-24
-0.5% -$1.34K 0.01% 113
2014
Q3 		$300K Sell
5,220
-56
-1% -$3.43K 0.01% 111
2014
Q2 		$353K Buy
5,276
+60
+1% +$4.06K 0.01% 135
2014
Q1 		$348K Buy
5,216
+100
+2% +$6.76K 0.01% 129
2013
Q4 		$341K Hold
5,116
– – 0.01% 126
2013
Q3 		$321K Buy
5,116
+60
+1% +$3.86K 0.02% 120
2013
Q2 		$316K Buy
+5,056
New +$321K 0.02% 129

Other funds holding GSK

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

WCM Investment Management's GSK Position: Q3 2015 in Review

WCM Investment Management sold out of GSK (GSK) in Q3 2015, closing a stake of 4,824 shares — an estimated $251K sold.

WCM Investment Management first reported a position in GSK in Q2 2013 and held it in 9 quarters. The position peaked at $353K in Q2 2014. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

  • WCM Investment Management reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
  • WCM Investment Management sold 4,824 GSK shares in Q3 2015, an estimated $251K.
  • WCM Investment Management first reported a position in GSK in Q2 2013 and held it in 9 quarters.
  • WCM Investment Management's GSK position peaked at $353K in Q2 2014.
  • 706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on WCM Investment Management's 13F filing for Q3 2015, filed 6 Nov 2015.